Cargando…
A plea for taking all available clinical information into account when assessing the predictive value of omics data
BACKGROUND: Omics data can be very informative in survival analysis and may improve the prognostic ability of classical models based on clinical risk factors for various diseases, for example breast cancer. Recent research has focused on integrating omics and clinical data, yet has often ignored the...
Autores principales: | Volkmann, Alexander, De Bin, Riccardo, Sauerbrei, Willi, Boulesteix, Anne-Laure |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657034/ https://www.ncbi.nlm.nih.gov/pubmed/31340753 http://dx.doi.org/10.1186/s12874-019-0802-0 |
Ejemplares similares
-
Added predictive value of omics data: specific issues related to validation illustrated by two case studies
por: Bin, Riccardo De, et al.
Publicado: (2014) -
A Plea for Neutral Comparison Studies in Computational Sciences
por: Boulesteix, Anne-Laure, et al.
Publicado: (2013) -
IPF-LASSO: Integrative L
(1)-Penalized Regression with Penalty Factors for Prediction Based on Multi-Omics Data
por: Boulesteix, Anne-Laure, et al.
Publicado: (2017) -
Statistical analysis of high-dimensional biomedical data: a gentle introduction to analytical goals, common approaches and challenges
por: Rahnenführer, Jörg, et al.
Publicado: (2023) -
Cost-effectiveness analysis has to consider all available evidence when informing inputs
por: Alvarez, Fabián P., et al.
Publicado: (2020)